Literature DB >> 16217978

Use of complementary and alternative medicine by parents of children with HIV infection and asthma and well children.

Jocelyn Y Ang1, Shibani Ray-Mazumder, Sharon A Nachman, Chokechai Rongkavilit, Basim I Asmar, Clement L Ren.   

Abstract

OBJECTIVE: Although the use of complementary and alternative medicine (CAM) in children is increasing, little is known about its use in children with human immunodeficiency virus (HIV) infection. This study investigated the use of CAM by parents of children with HIV infection (H), children with asthma (A), and well children (W). Our hypothesis was that parents of the H group are more likely to use CAM than parents of the W or A group because of the nature and severity of the illness.
MATERIALS AND METHODS: Parents of 152 subjects [H (n = 46), A (n = 53), and W (n = 53)] were interviewed on the use of CAM for their children, types of CAM, reasons for use/nonuse, methods of payment, and perceived benefits for their children.
RESULTS: Compared with parents of the W and A groups, parents of the H group were less likely to be employed, were less likely to have private insurance, were less likely to have a high school or college education, and were more likely to be black. Interestingly, 38% of the W parents used CAM in their children compared with 22% in the H group and 25% in the A group. More than 80% of all three groups paid out of pocket for their use of CAM in their children. Within these groups, H parents were more likely to want CAM as part of their child's medical care (H = 91% vs W = 75% and A = 67%, P = 0.02) and were more likely to believe that CAM was expensive (H = 78% vs W = 57% and A = 60%, P < 0.01).
CONCLUSIONS: Our study revealed a relatively high rate of CAM usage by parents of all three study groups. Although parents of children with HIV infection were more likely to want CAM as part of their children's medical care, their rate of CAM usage was not higher than that in well children. This may be related to their socioeconomic factors. A larger and more diverse study population may provide more information on factors contributing to CAM usage in chronically ill and well children.

Entities:  

Mesh:

Year:  2005        PMID: 16217978     DOI: 10.1097/01.smj.0000173089.51284.69

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

Review 1.  Health beliefs, treatment preferences and complementary and alternative medicine for asthma, smoking and lung cancer self-management in diverse Black communities.

Authors:  Maureen George
Journal:  Patient Educ Couns       Date:  2012-06-08

Review 2.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

3.  Complementary and alternative medicine use and quality of life in pediatric diabetes.

Authors:  Rachelle L McCarty; Wendy J Weber; Beth Loots; Cora Collette Breuner; Ann Vander Stoep; Lisa Manhart; Catherine Pihoker
Journal:  J Altern Complement Med       Date:  2010-02       Impact factor: 2.579

4.  Use of complementary and alternative medicine in children with asthma.

Authors:  Vanessa Torres-Llenza; Sanjit Bhogal; Michael Davis; Francine Ducharme
Journal:  Can Respir J       Date:  2010 Jul-Aug       Impact factor: 2.409

Review 5.  A systematic review of complementary and alternative medicine for asthma self-management.

Authors:  Maureen George; Maxim Topaz
Journal:  Nurs Clin North Am       Date:  2013-01-10       Impact factor: 1.208

6.  Use of natural health products in children: survey of parents in waiting rooms.

Authors:  Marshall Godwin; John Crellin; Maria Mathews; Nurun L Chowdhury; Leigh Anne Newhook; Andrea Pike; Farah McCrate; Rebecca Law
Journal:  Can Fam Physician       Date:  2013-08       Impact factor: 3.275

7.  Complementary or alternative? Patterns of complementary and alternative medicine (CAM) use among Finnish children.

Authors:  Sanna M Siponen; Riitta S Ahonen; Asa Kettis; Katri P Hämeen-Anttila
Journal:  Eur J Clin Pharmacol       Date:  2012-05-10       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.